Αρχική World News Emactuzumab reduces tumour size in patients with tenosynovial giant cell tumours World News Emactuzumab reduces tumour size in patients with tenosynovial giant cell tumours Από Ogkologos - 27 Οκτωβρίου, 2026 12 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Combination of Enzalutamide Plus Abiraterone Acetate and Prednisone Offers No Clinical... 6 Απριλίου, 2023 R2-ISS: an Improved and Simple Prognostic Staging System Allows Better Stratification... 1 Ιουνίου, 2022 EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan 13 Ιουλίου, 2023 EMA Recommends Extending Indications for Lisocabtagene Maraleucel 12 Νοεμβρίου, 2025 Φόρτωση περισσοτέρων HOT NEWS Thank you! New Type of Chemotherapy Bypasses Healthy Cells to Decrease Negative Side... Intensive care nurse describes his experience of female-centred care after breast... Stopping TKI Treatment Is Safe, Improves Quality of Life for Some...
